Gossamer Bio Inc expected to post a loss of 19 cents a share - Earnings Preview

Gossamer Bio

03/05/2024 12:54

* Gossamer Bio Inc  GOSS.OQ   GOSS.O  is expected to show no
change in quarterly revenue when it reports  results on May 7
(estimated) for the period ending March 31 2024
    * 
    * ​LSEG's mean analyst estimate for Gossamer Bio Inc is for
a loss
of 19 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 0.1%
in the last three months. ​
    * Wall Street's median 12-month price target for Gossamer
Bio Inc
is $4.00​, above​ its last closing price of $0.77. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  -0.19       -0.21      -0.21     Met     -1
 Sep. 30 2023  -0.24       -0.26      -0.21     Beat    17.8
 Jun. 30 2023  -0.48       -0.49      -0.45     Beat    8​
 Mar. 31 2023  -0.52       -0.53      -0.52     Beat    1.8
 ​​Dec.        -0.62       -0.62      -0.59     Beat    5.3
 31 2022                                                
 Sep. 30 2022  -0.66       -0.64      -0.65     Missed  -2.3​
 Jun. 30 2022  -0.68       -0.70      -0.74     Missed  -5.8
 Mar. 31 2022  -0.77       -0.77      -0.76     Beat    0.9
 This summary was machine generated May 3 at 11:54 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)